PATRICIA FOGELMAN: Open Payments
NPI 1841294808 · STATE COLLEGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$201 in 9 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $165 · 2025 $201
Food & beverage: $201
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 1 | $30 |
| Geron Corporation | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| ABBVIE INC. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| TAIHO ONCOLOGY, INC. | 1 | $16 |
| Stemline Therapeutics Inc. | 1 | $15 |
Products named: Enhertu, RYTELO, CALQUENCE, EMRELIS, ICLUSIG, VERZENIO, IBRANCE, LONSURF.
Industry payments across PA — which companies pay providers there.
